Figure 3. Effect of Bezafibrate (B) intervention (200 µmol/L, and 400 µmol/L in SCADD fibroblasts only) on menadione toxicity in each FAO disorder under variable conditions.

Logarithmic transformation followed by paired t-test compares menadione toxicity in each FAOD with and without Bezafibrate, under each experimental condition. This figure shows that Bezafibrate significantly reduced menadione toxicity in the SCAD and MTP/CPT2 deficient patient fibroblasts only, under all 4 experimental conditions (Table S5).